ter Maaten, Jozine M. http://orcid.org/0000-0002-4910-9336
Beldhuis, Iris E.
van der Meer, Peter http://orcid.org/0000-0002-9705-4413
Krikken, Jan A.
Postmus, Douwe
Coster, Jenifer E.
Nieuwland, Wybe
van Veldhuisen, Dirk J.
Voors, Adriaan A. http://orcid.org/0000-0002-5417-4415
Damman, Kevin http://orcid.org/0000-0003-0190-2228
Funding for this research was provided by:
Hartstichting (2020T012)
Article History
Received: 17 July 2023
Accepted: 3 August 2023
First Online: 28 August 2023
Competing interests
: J.M.t.M. is supported by a Dekker grant of the Dutch Heart Foundation (2020T012) for this study. J.M.t.M. declares speaker fees to her institution from Boehringer Ingelheim and Novartis. P.v.d.M. declares speaker and consultancy fees to his institution from Vifor Pharma, Novo Nordisk, Pfizer, AstraZeneca, Ionis and Pharma Nord. J.E.C. declares speaker fees from Novartis, and has received fees from Cardiolysis for participation on a DSMB or advisory board. A.A.V. has received research support and/or has been a consultant for AnaCardio, Bayer, BMI, Boehringer Ingelheim, Corteria, Cytokinetics, Eli Lily, Merck, Novartis, Novo Nordisk and Roche Diagnostics. K.D. declares speaker and consultancy fees to his institution from Boehringer Ingelheim, AstraZeneca, Abbott, FIRE1 and EchoSense. The other authors declare no competing interests.